A saffron-based nutritional supplement may possess the ability to reduce inflammation and improve the overall mental state of individuals diagnosed with Parkinson`s disease (PD). This promising discovery was made by researchers following a randomized clinical trial, the findings of which were published in the scientific journal *Food & Function*.
Study Methodology and Key Findings
The rigorous triple-blind, placebo-controlled investigation enrolled 92 patients with Parkinson`s disease. The participants were divided into two groups over a period of 12 weeks: one group received a daily dose of 100 milligrams of saffron powder, while the control group was administered a placebo.
The results indicated that participants consuming the saffron supplement showed a statistically significant decrease in C-reactive protein (CRP) levels—a recognized key biomarker for systemic inflammation. Crucially, the saffron group also demonstrated noticeable improvements in their cognitive performance.
Improved Quality of Life
In addition to physiological and cognitive benefits, patients in the saffron group reported a substantial reduction in the severity of anxiety, depression, and subjective distress. They also experienced significant enhancements in sleep quality and a decrease in general fatigue.
Positive trends were observed across several quality-of-life metrics, including improved mobility, better capacity for performing daily activities, and a general elevation of overall well-being. Importantly, the study confirmed the safety profile of the spice, as no adverse side effects were recorded during the trial period.
Scientific Rationale and Future Potential
The study authors hypothesize that the observed therapeutic effects stem from the potent antioxidant and anti-inflammatory properties inherent in saffron`s bioactive compounds.
The researchers emphasize that saffron should not be viewed as a substitute for standard medical therapy for Parkinson`s disease. However, the robust data generated by this study strongly indicate the potential of saffron as a safe, complementary supplement for managing PD symptoms, thereby justifying the need for extensive future clinical investigations.
